Estimations des analystes de Wall Street pour Ovid Therapeutics Inc. (OVID): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-0.08 | ||
| 2026-08-13 | $-0.08 | $-0.12 | +30.4% |
| 2026-05-12 | $-0.12 | $-0.12 | +0.0% |
| 2026-03-18 | $0.06 | $-0.10 | +160.0% |
| 2025-11-12 | $-0.17 | $-0.15 | -13.3% |
| 2025-08-13 | $-0.06 | $-0.16 | +62.5% |
| 2025-05-13 | $-0.14 | $-0.14 | +0.0% |
| 2025-03-11 | $-0.13 | $-0.16 | +18.8% |
Ratios de valorisation
| Prix / Valeur comptable | 0.96 |
| EV / EBITDA | -14.12 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | 0 | 0 | 0 | 0 | $12.6M | $208.4M | $1.5M | $392000 | $566000 | $7.3M |
| Coût des Ventes | 0 | $80310 | $141733 | 0 | 0 | 0 | 0 | 0 | 0 | $300000 |
| Marge Brute | -$56512 | -$80310 | -$142000 | 0 | $12.6M | $208.4M | $1.5M | $392000 | $566000 | $7.0M |
| R&D | $9.6M | $50.0M | $33.8M | $46.9M | $64.1M | $46.9M | $24.6M | $28.6M | $36.8M | $25.6M |
| Frais Généraux | $12.9M | $15.0M | $19.1M | $19.3M | $30.6M | $37.2M | $32.4M | $29.6M | $25.7M | $24.1M |
| Charges Opérationnelles | $22.5M | $65.0M | $52.9M | $61.4M | $94.0M | $84.2M | $57.1M | $59.7M | $62.5M | $49.4M |
| Résultat Opérationnel | -$22.5M | -$65.0M | -$52.9M | -$61.4M | -$81.4M | $124.2M | -$55.5M | -$59.3M | -$61.9M | -$42.4M |
| EBITDA | -$22.5M | -$64.7M | -$52.8M | -$61.2M | -$81.1M | $124.4M | -$54.2M | -$57.0M | -$57.8M | -$17.1M |
| Charges d'Intérêt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Avant Impôts | -$22.4M | -$64.8M | -$52.0M | -$60.5M | -$81.0M | $124.2M | -$54.2M | -$52.3M | -$26.4M | -$17.4M |
| Impôts | -$950 | -$80310 | 0 | 0 | 0 | $1.3M | 0 | 0 | 0 | 0 |
| Résultat Net | -$22.4M | -$64.8M | -$52.0M | -$60.5M | -$81.0M | $122.8M | -$54.2M | -$52.3M | -$26.4M | -$17.4M |
| BPA | $-1.14 | $-3.35 | $-2.11 | $-1.51 | $-1.39 | $1.78 | $-0.77 | $-0.74 | $-0.37 | $-0.24 |
| BPA Dilué | $-1.14 | $-3.35 | $-2.11 | $-1.51 | $-1.39 | $1.76 | $-0.77 | $-0.74 | $-0.37 | $-0.24 |
| Actions en Circulation (Diluées) | $19.6M | $19.3M | $24.6M | $39.2M | $58.5M | $68.1M | $70.4M | $70.6M | $70.9M | $73.7M |
Prix
| Prix | $2.68 |
| Capitalisation | $500M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: CLNN · CNTB · CNTX · IFRX · IMA · KLRS · MGNX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de OVID: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions